| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| David E Stickler, Laura L Stickle. Single-fiber electromyography during menstrual exacerbation and ovulatory suppression in MuSK antibody-positive myasthenia gravis. Muscle & nerve. vol 35. issue 6. 2007-07-12. PMID:17221882. |
the potential long-term benefit of ovulatory suppression in musk antibody-positive myasthenia gravis is discussed. |
2007-07-12 |
2023-08-12 |
Not clear |
| Maria Elena Farrugia, Domenico Marco Bonifati, Linda Clover, Judy Cossins, David Beeson, Angela Vincen. Effect of sera from AChR-antibody negative myasthenia gravis patients on AChR and MuSK in cell cultures. Journal of neuroimmunology. vol 185. issue 1-2. 2007-06-06. PMID:17335909. |
effect of sera from achr-antibody negative myasthenia gravis patients on achr and musk in cell cultures. |
2007-06-06 |
2023-08-12 |
Not clear |
| Erik H Niks, Jan B M Kuks, Jan J G M Verschuure. Epidemiology of myasthenia gravis with anti-muscle specific kinase antibodies in The Netherlands. Journal of neurology, neurosurgery, and psychiatry. vol 78. issue 4. 2007-03-29. PMID:17056627. |
the epidemiology of myasthenia gravis subtypes and the frequency of antibodies to muscle-specific kinase (musk) was studied in patients with generalised myasthenia gravis without anti-acetylcholine receptor antibodies who had an onset of symptoms between 1990 and 2004 in a well-defined region in the netherlands. |
2007-03-29 |
2023-08-12 |
Not clear |
| Erik H Niks, Jan B M Kuks, Jan J G M Verschuure. Epidemiology of myasthenia gravis with anti-muscle specific kinase antibodies in The Netherlands. Journal of neurology, neurosurgery, and psychiatry. vol 78. issue 4. 2007-03-29. PMID:17056627. |
musk antibodies were found in 22% of patients with generalised myasthenia gravis without anti-acetylcholine receptor antibodies. |
2007-03-29 |
2023-08-12 |
Not clear |
| Erik H Niks, Jan B M Kuks, Jan J G M Verschuure. Epidemiology of myasthenia gravis with anti-muscle specific kinase antibodies in The Netherlands. Journal of neurology, neurosurgery, and psychiatry. vol 78. issue 4. 2007-03-29. PMID:17056627. |
nationwide, 35 patients with musk myasthenia gravis were identified, yielding a prevalence of 1.9 per million (95% confidence interval (ci) 1.22 to 2.59) and an annual incidence 0.10 per million person-years (95% ci 0.06 to 0.14). |
2007-03-29 |
2023-08-12 |
Not clear |
| F Deymeer, O Gungor-Tuncer, V Yilmaz, Y Parman, P Serdaroglu, C Ozdemir, A Vincent, G Saruhan-Direskenel. Clinical comparison of anti-MuSK- vs anti-AChR-positive and seronegative myasthenia gravis. Neurology. vol 68. issue 8. 2007-03-21. PMID:17310034. |
we compared 65 anti-acetylcholine receptor (achr)-negative myasthenia gravis (mg) patients, including 32 anti-muscle-specific tyrosine kinase (musk)-positive (49%) and 33 anti-musk-negative (seronegative) (51%) patients, with 161 anti-achr-positive mg patients. |
2007-03-21 |
2023-08-12 |
Not clear |
| S Kuwabara, Y Nemoto, S Misawa, H Takahashi, N Kawaguchi, T Hattor. Anti-MuSK-positive myasthenia gravis: neuromuscular transmission failure in facial and limb muscles. Acta neurologica Scandinavica. vol 115. issue 2. 2007-03-20. PMID:17212617. |
the presence of antibodies against muscle-specific receptor tyrosine kinase (musk) appears to define a subgroup of patients with myasthenia gravis (mg) characterized by weakness predominant in bulbar, facial and neck muscles compared with anti-acetylcholine receptor (achr) antibody-positive mg. to investigate the patterns and severity of neuromuscular transmission failure in different muscles in musk-positive mg, we performed single fiber electromyography (sfemg) in the facial (frontalis) and limb (extensor digitorum communis, edc) muscles in three anti-musk-positive patients, and compared results with those of 11 anti-achr-positive patients. |
2007-03-20 |
2023-08-12 |
Not clear |
| Maria E Farrugia, Robin P Kennett, David Hilton-Jones, John Newsom-Davis, Angela Vincen. Quantitative EMG of facial muscles in myasthenia patients with MuSK antibodies. Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology. vol 118. issue 2. 2007-03-09. PMID:17157556. |
our aim was to study the pathophysiological process leading to facial muscle atrophy in 13 patients with musk antibody positive myasthenia gravis (musk-mg), and to compare with findings from 12 acetylcholine receptor antibody positive myasthenia patients (achr-mg), selected because they suffered from the same degree of disease severity and required similar treatment. |
2007-03-09 |
2023-08-12 |
Not clear |
| K Xu, S Jha, W Hoch, S E Drye. Delayed synapsing muscles are more severely affected in an experimental model of MuSK-induced myasthenia gravis. Neuroscience. vol 143. issue 3. 2007-03-06. PMID:17081697. |
myasthenia gravis can be induced in mice by injecting the extracellular domain of rat muscle-specific kinase (musk), a transmembrane receptor tyrosine kinase involved in agrin signaling at the neuromuscular junction. |
2007-03-06 |
2023-08-12 |
mouse |
| K Xu, S Jha, W Hoch, S E Drye. Delayed synapsing muscles are more severely affected in an experimental model of MuSK-induced myasthenia gravis. Neuroscience. vol 143. issue 3. 2007-03-06. PMID:17081697. |
about 5-10% of human myasthenia gravis patients have autoantibodies against musk. |
2007-03-06 |
2023-08-12 |
mouse |
| K Xu, S Jha, W Hoch, S E Drye. Delayed synapsing muscles are more severely affected in an experimental model of MuSK-induced myasthenia gravis. Neuroscience. vol 143. issue 3. 2007-03-06. PMID:17081697. |
these results suggest a basis for the differential susceptibility of muscles in different classes of myasthenia gravis patients, including patients with autoantibodies against musk. |
2007-03-06 |
2023-08-12 |
mouse |
| Hirokatsu Takahashi, Naoki Kawaguchi, Yuko Nemoto, Takamichi Hattor. High-dose intravenous immunoglobulin for the treatment of MuSK antibody-positive seronegative myasthenia gravis. Journal of the neurological sciences. vol 247. issue 2. 2006-10-31. PMID:16876198. |
high-dose intravenous immunoglobulin for the treatment of musk antibody-positive seronegative myasthenia gravis. |
2006-10-31 |
2023-08-12 |
Not clear |
| Hirokatsu Takahashi, Naoki Kawaguchi, Yuko Nemoto, Takamichi Hattor. High-dose intravenous immunoglobulin for the treatment of MuSK antibody-positive seronegative myasthenia gravis. Journal of the neurological sciences. vol 247. issue 2. 2006-10-31. PMID:16876198. |
we treated two patients with anti-muscle specific tyrosine kinase (musk)-antibody positive seronegative myasthenia gravis (mg) with high-dose intravenous gammaglobulin (ivig) and evaluated their clinical courses. |
2006-10-31 |
2023-08-12 |
Not clear |
| A Rostedt Punga, K Ahlqvist, E Bartoccioni, F Scuderi, M Marino, A Suomalainen, H Kalimo, E V Stålber. Neurophysiological and mitochondrial abnormalities in MuSK antibody seropositive myasthenia gravis compared to other immunological subtypes. Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology. vol 117. issue 7. 2006-09-05. PMID:16737845. |
neurophysiological and mitochondrial abnormalities in musk antibody seropositive myasthenia gravis compared to other immunological subtypes. |
2006-09-05 |
2023-08-12 |
Not clear |
| Anna Rostedt Punga, Roland Flink, Håkan Askmark, Erik V Stålber. Cholinergic neuromuscular hyperactivity in patients with myasthenia gravis seropositive for MuSK antibody. Muscle & nerve. vol 34. issue 1. 2006-08-11. PMID:16453324. |
cholinergic neuromuscular hyperactivity in patients with myasthenia gravis seropositive for musk antibody. |
2006-08-11 |
2023-08-12 |
Not clear |
| Anna Rostedt Punga, Roland Flink, Håkan Askmark, Erik V Stålber. Cholinergic neuromuscular hyperactivity in patients with myasthenia gravis seropositive for MuSK antibody. Muscle & nerve. vol 34. issue 1. 2006-08-11. PMID:16453324. |
a 75-year-old man with severe oculobulbar myasthenia gravis (mg) treated with acetylcholine esterase inhibitors (acheis) was found to have muscle-specific tyrosine kinase (musk) antibodies. |
2006-08-11 |
2023-08-12 |
Not clear |
| H Murai, T Noda, E Himeno, Y Kawano, Y Ohyagi, H Shiraishi, M Motomura, J Kir. Infantile onset myasthenia gravis with MuSK antibodies. Neurology. vol 67. issue 1. 2006-08-08. PMID:16832105. |
infantile onset myasthenia gravis with musk antibodies. |
2006-08-08 |
2023-08-12 |
Not clear |
| Smita Jha, Kaiping Xu, Takahiro Maruta, Minako Oshima, Dennis R Mosier, M Zouhair Atassi, Werner Hoc. Myasthenia gravis induced in mice by immunization with the recombinant extracellular domain of rat muscle-specific kinase (MuSK). Journal of neuroimmunology. vol 175. issue 1-2. 2006-07-26. PMID:16697051. |
myasthenia gravis induced in mice by immunization with the recombinant extracellular domain of rat muscle-specific kinase (musk). |
2006-07-26 |
2023-08-12 |
mouse |
| Jee-Young Lee, Jung Joon Sung, Joong-Yang Cho, Dong-Hoon Oh, Hyun-Jung Kim, Jong-Ha Park, Kwang Woo Lee, Young-Chul Choi, Angela Vincen. MuSK antibody-positive, seronegative myasthenia gravis in Korea. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia. vol 13. issue 3. 2006-07-06. PMID:16546389. |
musk antibody-positive, seronegative myasthenia gravis in korea. |
2006-07-06 |
2023-08-12 |
Not clear |
| Jee-Young Lee, Jung Joon Sung, Joong-Yang Cho, Dong-Hoon Oh, Hyun-Jung Kim, Jong-Ha Park, Kwang Woo Lee, Young-Chul Choi, Angela Vincen. MuSK antibody-positive, seronegative myasthenia gravis in Korea. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia. vol 13. issue 3. 2006-07-06. PMID:16546389. |
several reports from western countries suggest differences in the clinical features of patients with muscle specific kinase (musk) antibody-positive and -negative seronegative myasthenia gravis (mg). |
2006-07-06 |
2023-08-12 |
Not clear |